Sign Up to like & get
recommendations!
1
Published in 2022 at "Advanced materials"
DOI: 10.1002/adma.202109955
Abstract: Venous thromboembolism (VTE) is a prevalent public health issue worldwide. Before treatment, spatiotemporally accurate thrombus detection is essential. However, with the currently available imaging technologie, this is challenging. Herein, the development of a novel fibrin-specific…
read more here.
Keywords:
thrombi;
fibrin rich;
specific nanoprobe;
fibrin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2021.02.060
Abstract: Background Bone marrow-derived mesenchymal stromal cells (BMMSC) can be expanded ex vivo, they have the ability to regenerate cartilage for accelerated knee recovery as already demonstrated in several studies. This study evaluated the influence BMMSC…
read more here.
Keywords:
plasma membrane;
animals submitted;
fibrin rich;
bmmsc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of NeuroInterventional Surgery"
DOI: 10.1136/neurintsurg-2017-013507
Abstract: Background Despite advances in revascularization tools for large vessel occlusion presenting as acute ischemic stroke, a significant subset of clots remain recalcitrant to current strategies. We assessed the effectiveness of a novel thrombectomy device that…
read more here.
Keywords:
geometric clot;
fibrin rich;
stroke model;
fibrin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of NeuroInterventional Surgery"
DOI: 10.1136/neurintsurg-2017-snis.149
Abstract: Introduction Recent meta-analysis of randomized clinical trials has shown that endovascular intervention yields higher rates of revascularization and superior functional outcomes as compared to standard medical therapy in the setting of emergent large vessel occlusion…
read more here.
Keywords:
thrombus analogs;
clinical thrombi;
fibrin rich;
thrombus ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.790002
Abstract: Stroke is one of the most prevalent diseases worldwide caused primarily by a thrombotic vascular occlusion that leads to cell death. To date, t-PA (tissue-type plasminogen activator) is the only thrombolytic therapy approved which targets…
read more here.
Keywords:
damage;
thrombosis;
fibrin rich;
stroke ... See more keywords